Medicare Enrolled

Rochelle Nazarian, NP

Nurse Practitioner - Family · Danvers, MA
140 COMMONWEALTH AVE, Danvers, MA 01923
9787626262
Registered in NPPES since 2006
NPI: 1417986860 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Nazarian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Nazarian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Nazarian

Rochelle Nazarian is a nurse practitioner - family in Danvers, MA, with 20 years of NPI registration.

Between the years covered by Open Payments, Nazarian received a total of $27,010 from 56 pharmaceutical and/or device companies across 935 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Nazarian is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $27,010 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$27,010
Total received (2021-2024)
Avg $6,753/year across 4 years
Top 0% in MA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
935
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$7,722
2023
$7,357
2022
$5,892
2021
$6,040

Payments by company (2024)

SHIELD THERAPEUTICS INC
$4,082
AstraZeneca Pharmaceuticals LP
$693
ABBVIE INC.
$605
Lilly USA, LLC
$304
Amgen Inc.
$294
Otsuka America Pharmaceutical, Inc.
$259
Bayer Healthcare Pharmaceuticals Inc.
$235
PFIZER INC.
$157
Novo Nordisk Inc
$154
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$150
GlaxoSmithKline, LLC.
$140
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$123
Astellas Pharma US Inc
$101
Exact Sciences Corporation
$97
Phathom Pharmaceuticals, Inc.
$74
Merck Sharp & Dohme LLC
$68
Ardelyx, Inc.
$44
Lundbeck LLC
$28
Abbott Laboratories
$23
Novartis Pharmaceuticals Corporation
$20
Inspire Medical Systems, Inc.
$18
Gilead Sciences, Inc.
$18
Lucid Diagnostics Inc.
$17
Echosens North America, Inc.
$16
Top 3 companies account for 69.7% of 2024 payments
All-time payments by company (2021-2024) ›
SHIELD THERAPEUTICS INC
$4,082
ABBVIE INC.
$3,244
AstraZeneca Pharmaceuticals LP
$3,094
Shield Therapeutics Inc
$2,459
Amgen Inc.
$1,549
AbbVie Inc.
$1,334
Novo Nordisk Inc
$1,334
Lilly USA, LLC
$1,049
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$710
Bayer Healthcare Pharmaceuticals Inc.
$613
Corium, LLC
$584
Boehringer Ingelheim Pharmaceuticals, Inc.
$549
GlaxoSmithKline, LLC.
$549
Biohaven Pharmaceuticals, Inc.
$526
Biohaven Pharmaceutical Holding Company Ltd.
$488
Astellas Pharma US Inc
$370
IDORSIA PHARMACEUTICALS US INC
$350
Janssen Pharmaceuticals, Inc
$343
RedHill Biopharma Inc.
$341
Bayer HealthCare Pharmaceuticals Inc.
$341
Otsuka America Pharmaceutical, Inc.
$336
PFIZER INC.
$307
Novartis Pharmaceuticals Corporation
$261
Amarin Pharma Inc.
$254
Merck Sharp & Dohme LLC
$207
Alkermes, Inc.
$156
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$150
Galderma Laboratories, L.P.
$133
Takeda Pharmaceuticals U.S.A., Inc.
$128
Exact Sciences Corporation
$113
Sunovion Pharmaceuticals Inc.
$98
Merck Sharp & Dohme Corporation
$93
Eisai Inc.
$84
Nestle HealthCare Nutrition Inc.
$75
Phathom Pharmaceuticals, Inc.
$74
QOL Medical, LLC
$71
Mylan Specialty L.P.
$58
Ironwood Pharmaceuticals, Inc
$57
Genentech USA, Inc.
$53
Ardelyx, Inc.
$44
Esperion Therapeutics, Inc.
$44
ITI, Inc.
$42
Lundbeck LLC
$28
NESTLE HEALTHCARE NUTRITION INC.
$27
SANOFI-AVENTIS U.S. LLC
$23
Abbott Laboratories
$23
EISAI INC.
$19
Inspire Medical Systems, Inc.
$18
Gilead Sciences, Inc.
$18
Kowa Pharmaceuticals America, Inc.
$17
Lucid Diagnostics Inc.
$17
Echosens North America, Inc.
$16
Biogen, Inc.
$15
TherapeuticsMD, Inc.
$15
Hikma Pharmaceuticals USA
$14
Eyevance Pharmaceuticals LLC
$14
Top 3 companies account for 38.6% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ACCRUFER · ADUHELM · AIRSUPRA · ANNOVERA · ANORO ELLIPTA · AREXVY · ARISTADA · AZSTARYS · Aimovig · Azstarys · BAQSIMI · BELSOMRA · BEXSERO · BOTOX · BREZTRI · BRILINTA · CAPLYTA · COMIRNATY · CREON · Cologuard Collection Kit · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FASENRA · FREESTYLE LIBRE 3 · FibroScan · GARDASIL · GARDASIL 9 · GEMTESA · IBSRELA · INSPIRE · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LOKELMA · LYBALVI · Linzess · Livalo · MOTEGRITY · MOUNJARO · MYRBETRIQ · Mitigare · Movantik · Myrbetriq · NEXLETOL · NURTEC ODT · OFEV · Otezla · Ozempic · PAXLOVID · PREVNAR 20 · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · STIOLTO RESPIMAT · SUCRAID · Saxenda · TEZSPIRE · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · TRUMENBA · Talicia · Tobradex ST · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veozah · XARELTO · XIFAXAN · Xofluza · Yupelri · ZENPEP · ZEPBOUND
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nurse practitioner - family in Danvers?
Compare family nurse practitioners in the Danvers area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners in nearby ZIP areas
2,155
County median income
$99,431
Nearest hospital to ZIP centroid (approximate)
NORTHEAST HOSPITAL CORPORATION
4.2 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Nazarian is a nurse practitioner - family, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Nazarian receive payments from pharmaceutical companies?
Yes. Nazarian received a total of $27,010 from 56 companies across 935 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Nazarian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →